Skip to main content
. 2022 Oct 3;13:1007315. doi: 10.3389/fphar.2022.1007315

FIGURE 2.

FIGURE 2

Summary of a few drugs repurposed for neurodegenerative diseases, adapted from (Durães et al., 2018) via CC by 4.0 license.